Perspectives

Therigy Selected to Gator100

Written by admin | Feb 28, 2019 10:33:00 PM

Maitland, FL, February 28, 2019 - For the fourth year now, Therigy, LLC, the trusted source for specialty pharmacy technology and consulting services, was named to the University of Florida’s Gator100 list.   

 

Sponsored by the UF Alumni Association, in partnership with the UF Entrepreneurship & Innovation Center, the Gator100 recognizes the 100 fastest-growing businesses owned or led by UF alumni.  Ernst & Young calculated each company’s compound annual growth rate (CAGR) over the past three years to generate the ranking.

 

“The Gator100 honors UF alumni from across the university who are founding and growing amazing companies around the country,” said Kent Fuchs, president of the University of Florida. “It’s an incredible affirmation of the innovative and entrepreneurial spirit of the Gator Nation.”

 

Company Co-Founder and Chief Executive Officer, Joe Morse, BA, class of 1995, and Russel Allinson, Executive Chairman, co-founded Therigy in 2006.  Over the thirteen years, Therigy has established a base of the leading specialty pharmacies across the country.  Therigy provides best in class solutions and services to equip pharmacies to standardize and scale patient care. 

 

“Therigy is very grateful to be named to the University of Florida’s Gator 100 list, states Joe Morse, CEO, Therigy.  “It’s quite the accomplishment year after year to be named as one of the top 100 companies.  This is a great reflection of our hard work and passion for high quality consistent patient care.”

 

View the full list of Gator100 honorees at gator100.ufl.edu.

 

About Therigy

Therigy, LLC, an affiliate of CPS Solutions, LLC, provides patient-focused specialty therapy management software and services. Therigy equips pharmacy stakeholders with the tools to standardize and scale patient management programs—with a depth and consistency of clinical care not possible before—helping them to grow their patient population, deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends.